ETFs
A
ARCT
Arcturus Therape
6.97
+0.08+1.16%After Hours: 6.90 -0.07 -1.00%19:41 06/11 EDT
OPEN/PREV CLOSE6.89/6.89
TODAY RANGE6.71-7.04
VOL316.39K
MARKET CAP198.11M
52 WEEK RANGE5.85-24.17
AVG VOL (3M)451.40K
% TURNOVER1.11%
TURNOVER--
P/E (TTM)-2.4752
% RANGE4.64%
EPS(TTM)-2.8159
P/E(FORWARD)-1.7918
P/B1.035
BVPS6.73
DIVIDEND--
P/S2.414
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP182.29M
SHARES OUTSTANDING28.42M
NEXT EARNINGS08/10-08/14
FREE FLOAT26.15M
LOT SIZE1
EX-DATE11/16/2017
News
Press Releases
Financial Reports
Profile
TipRanks·6d ago
Arcturus Shareholders Back Board, Pay, and Auditor
TipRanks·05/20 04:33
Arcturus Therapeutics’ Earnings Call: mRNA Bets vs. Burn
TipRanks·05/09 01:17
Arcturus Therapeutics Signals Progress Amid Revenue Slip
Seeking Alpha·05/08 04:32
Arcturus outlines 12-week ARCT-032 Phase II enrollment and extends cash runway beyond Q2 2028
TipRanks·05/07 21:28
Arcturus Therapeutics Reports Q1 Results, Advances Rare Disease Pipeline
Benzinga·05/07 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
Reuters·05/07 20:09
Arcturus Therapeutics Q1 revenue drops sharply, net loss widens
Seeking Alpha·05/07 20:05
Arcturus Therapeutics GAAP EPS of -$0.95 beats by $0.04, revenue of $2.06M misses by $4.81M
Same Industry
Name/Symbol
Change%
Price